As has been the case the past few years, the annual American Society of Clinical Oncology meeting, which just wrapped up in Chicago, was the latest referendum on immunotherapy. But this year, not only did the meeting feature scientific developments for... Read more »
Bioptigen, a medical device firm that developed and commercialized a non-invasive scanning technology for ophthalmic procedures, has caught the eye of a German diagnostics company now set to buy the startup.
Leica Microsystems has announced a definitive agreement to acquire... Read more »
BioDelivery Sciences International has added $20.7 million to its coffers as the specialty pharmaceutical company prepares for the commercial launch of its opioid addiction treatment.
Raleigh, NC-based BioDelivery (NASDAQ: BDSI) secured the debt funding from MidCap Financial. BioDelivery’s total debt... Read more »
Irritable bowel syndrome symptoms range from abdominal pain to diarrhea, but for years, patients had no FDA-approved treatment to turn to for relief. That changes with the agency’s approval of two new drugs that were originally developed by North Carolina pharmaceutical... Read more »
Two recent happenings prompted this column. First, Orexigen Therapeutics drew fire from, well, nearly everyone earlier this month for an improper release of data related to its weight-loss drug Contrave. The second happening is Memorial Day weekend.
I’m assuming you, like... Read more »
The winning teams were announced today in the Neuro Startup Challenge, a two-year-old virtual accelerator that helps academic researchers and entrepreneurs build companies around promising technologies developed by NIH researchers.
The 13 winners include a team from the Medical College... Read more »
The path of a tiny Texas startup to the multi-billion dollar chemicals market crosses through the tobacco fields of North Carolina. If it’s successful, the company’s technology could also save the lives of millions of sharks.
That’s the circuitous course charted... Read more »
[Updated 5/19/15, 10:40 a.m. See below.] The push to regulate increasingly popular ridesharing services like Uber and Lyft has shifted from city halls to state capitol buildings—with implications for the companies’ reputations and expansion plans, as well as the... Read more »
Cree, the LED lighting and semiconductor technologies company, is laying the groundwork to spin off one of its business units as a separate company, supported by an initial public stock offering.
Durham, NC-based Cree (NASDAQ: CREE) disclosed Monday... Read more »
“It’s like a mini-Davos.”
That’s the way one leading venture capitalist describes Xconomy’s Napa Summit. And while he is perhaps a bit effusive, we do believe our annual retreat in wine country is something special. Maybe you can judge for yourself.... Read more »